Insomnia and hypertension: A misty landscape
- PMID: 30874341
- PMCID: PMC8030291
- DOI: 10.1111/jch.13519
Insomnia and hypertension: A misty landscape
Keywords: ambulatory blood pressure monitoring; blood pressure; hypertension; insomnia; suvorexant.
Conflict of interest statement
The authors report no specific funding in relation to this research and no conflicts of interest to disclose.
Comment on
-
Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER-1 study.J Clin Hypertens (Greenwich). 2019 Jul;21(7):896-903. doi: 10.1111/jch.13505. Epub 2019 Mar 15. J Clin Hypertens (Greenwich). 2019. PMID: 30874378 Free PMC article. Clinical Trial.
References
-
- Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med. Rev. 2010;14:19‐31. - PubMed
-
- Osborne R. First‐in‐class insomnia drug on the brink of approval nod. Nat Rev Drug Discov. 2013;12:492‐493. - PubMed
-
- Crow JM. Insomnia: chasing the dream. Nature. 2013;497:S16‐S18. - PubMed
-
- Coleman PJ, Gotter AL, Herring WJ, Winrow CJ, Renger JJ. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annu Rev Pharmacol Toxicol. 2017;57:509‐533. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
